Abstract:Precise and rapid monitoring of metabolites in biofluids is a desirable but unmet goal for disease diagnosis and management. Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) exhibits advantages in metabolite analysis. However, the low accuracy in quantification of the technique limits its transformation to clinical usage. We report herein the use of Au nanoparticle arrays self-assembled at liquid–liquid interfaces for mass spectrometry (MS)-based quantitative biofluids metabolic profiling. The two-dimensional arrays feature uniformly and closely packed Au nanoparticles with 3 nm interparticle gaps. The experimental study and theoretical simulation show that the arrays exhibit high photothermal conversion and heat confinement effects, which enhance the laser desorption/ionization efficacy. With the nanoscale roughness, the AuNP arrays as laser desorption/ionization substrates can interrupt the coffee-ring effect during droplet evaporation. Therefore, high reproducibility (RSD <5%) is obtained, enabling accurate quantitative analysis of diverse metabolites from 1 μL of biofluids in seconds. By quantifying glucose in the cerebrospinal fluid (CSF), it allows us to identify patients with brain infection and rapidly evaluate the clinical therapy response. Consequently, the method shows potential in advanced metabolite analysis and biomedical diagnostics.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c20944?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c20944</a>.SEM images of the ISANAS (Figure S1); SEM images and UV–vis absorbance spectrum and optical photograph of AuNPs (−) (Figure S2); SEM images and UV–vis absorbance spectrum and optical photograph of AuNPs (+) (Figure S3); LDI-MS detection of 1 nmol glucose using the ISANAS with different amount of AuNPs (Figure S4); LDI-MS detection of 1 nmol glucose, arginine, GSH and reserpine using CHCA as matrix (Figure S5); LDI-MS detection of glucose using AuNPs aggregates (Figure S6); MS imaging of glucose on different ISANAS substrates (Figure S7); MS/MS spectra of GSH at m/z of 330, 352, and 374 using ISANAS-assisted LDI-MS (Figure S8); MS/MS spectra of lactic acid standard sample and the CSF signal at m/z of 113 (Figure S9); MS/MS spectra of glucose standard sample and the CSF signal at m/z of 203 (Figure S10); and ISANAS-assisted LDI-MS analysis of glucose in water with 1 mM cellobiose as internal standard (Figure S11) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c20944/suppl_file/am0c20944_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Host-Guest Self-Assembled Interfacial Nanoarrays for Precise Metabolic Profiling

DNA Assay Based on Monolayer-Barcoded Nanoparticles for Mass Spectrometry in Combination with Magnetic Microprobes.

Self-Assembled Au Nanoparticle Arrays for Precise Metabolic Assay of Cerebrospinal Fluid

Engineering a Universal and Fully Automatic Analyzer for Multichannel and On-Site Biochemical Detection in Body Fluids

Plasmonic Array Assisted Mass Spectrometry for Preferential Metabolite Detection

Super-assembled sandwich-like Au@MSN@Ag nanomatrices for high-throughput and efficient detection of small biomolecules

Multidimensional Interactive Cascading Nanochips for Detection of Multiple Liver Diseases via Precise Metabolite Profiling

Capture, Enrichment, and Mass Spectrometric Detection of Low-Molecular-Weight Biomarkers with Nanoporous Silicon Microparticles

In Vitro Diagnostic Examination and Prognosis Surveillance by Hierarchical Heterojunction-Assisted Metabolic Analysis.

A Non-Targeting Magnetic Metal-Organic Framework Probe for Highly Specific Peptide-Mediated Precise Disease Monitoring

Mass Nanotags Mediate Parallel Amplifications on Nanointerfaces for Multiplexed Profiling of RNAs.

Nanoconfined liquid phase nanoextraction combined with in-fiber derivatization for simultaneous quantification of seventy amino-containing metabolites in plasma by LC-MS/MS: Exploration of lung cancer screening model

Unraveling the drug distribution in brain enabled by MALDI MS imaging with laser-assisted chemical transfer

Ultra‐Fast Label‐Free Serum Metabolic Diagnosis of Coronary Heart Disease via a Deep Stabilizer

Hollow Crystallization COF Capsuled MOF Hybrids Depict Serum Metabolic Profiling for Precise Early Diagnosis and Risk Stratification of Acute Coronary Syndrome

TA@Au Nanoflower-assisted Laser Desorption/Ionization Mass Spectrometry for Metabolite Detection

Zr-Fc MOF Nanosheets Based Mass Spectrometry Platform for Metabolites Detection

Yolk-shell Ni/NiO anchored on N-doped graphene synthesized as dual-ion MALDI matrix for detecting and imaging bioactive small molecules

Label-free Single-molecule Immunoassay

A sensitive liquid chromatography−tandem mass spectrometry method for determination biomarkers of monoamine neurotransmitter disorders in cerebrospinal fluid

Peptide and Protein Assays Using Customizable Bio-Affinity Arrays Combined with Ambient Ionization Mass Spectrometry